Piper Sandler Reiterates Overweight on Zoetis, Lowers Price Target to $195
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg has reiterated an Overweight rating on Zoetis (NYSE:ZTS) but lowered the price target from $220 to $195.
April 16, 2024 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler reaffirms an Overweight rating on Zoetis but reduces the price target to $195 from $220.
The reiteration of an Overweight rating suggests continued confidence in Zoetis' fundamentals, while the price target reduction may reflect adjustments in market conditions or company valuation. This mixed signal could lead to short-term market uncertainty for ZTS shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100